A recombinant prostaglandin G/H (PGH) synthase gene has been expressed in vitro in bovine pulmonary artery endothelial cells and in vivo in rabbits by transfection with a plasmid using cationic liposomes. Transfection of bovine pulmonary artery endothelial cells with the PGH synthase cDNA resulted in increased intracellular PGH synthase protein (determined by Western blot analysis) and increased release of prostacyclin. Rabbits intravenously transfected with the PGH synthase gene had increased plasma levels of prostacyclin and PGE2, and their lungs produced increased amounts of the same eicosanoids. In an in situ, perfused preparation of PGH synthase transfected rabbit lungs, the pressor response to endotoxin was markedly attenuated. In addition, pulmonary edema and release of thromboxane B2 into the perfusate after endotoxin infusion were markedly decreased in transfected lungs compared to controls (animals transfected with a pCMV4 construct that did not contain a cDNA insert). The data suggest that augmented endogenous production of prostacyclin and PGE2, achieved by liposome-mediated gene transfer, protects the lungs from endotoxin. This may be caused in part by suppression ofendotoxin-stimulated thromboxane B2 production. Modification of lipid mediator responses by in vivo transfection is a potential approach to the therapy of acute lung injury. (J. Clin.
Introduction
In vivo transfer of functioning genes into the lungs of animals has been accomplished for a-1 antitrypsin, several reporter genes, and the cystic fibrosis transmembrane conductance regulator (1) (2) (3) (4) (5) (6) (7) . In those studies, gene expression was demonstrated by immunohistochemical staining, reverse transcriptase PCR, or the presence of the reporter gene product, but alterations in organ function were not reported. Effective human gene therapy will require a sufficent level of gene expression to affect physiological responses. We recently reported in vivo transgene expression by cationic liposome mediated delivery of DNA to the lungs by intravenous and aerosol routes (1) (2) (3) 7) . In the present report, we demonstrate successful intravenous delivery of the prostaglandin G/H (PGH)' synthase gene, consequent increases in the lipid mediator products of this enzyme, and striking protection of the lung from the effects of exposure to endotoxin.
PGH synthase catalyzes the conversion of arachidonic acid to prostaglandin endoperoxides, precursors to biologically active compounds including thromboxanes, prostacyclin, PGE2 and other eicosanoids. PGH synthase is the rate limiting step in the cyclooxygenase pathway of arachidonic acid metabolism (8, 9) . Prostacyclin and PGE2 are the principal eicosanoids generated by endothelial cells, and there is evidence that exogenous delivery of PGE2 can protect the lungs from endotoxin (10) . Since even a small increase in the expression of PGH synthase, a catalytically active enzyme, could result in a marked increase in the local synthesis of prostaglandins, we reasoned that this approach might result in physiologic effects with less in vivo transgene expression than would otherwise be required.
In the present paper, we demonstrate that transfection of bovine pulmonary artery endothelial cells (BPAEC) with the cDNA coding for ovine PGH synthase results in an increase in both prostacyclin release and intracellular PGH synthase protein. In vivo delivery of this cDNA to rabbits yields increased lung generation of PGE2 and prostacyclin metabolite. In vivo transfection ofrabbits with the ovine PGH synthase gene markedly reduces endotoxin stimulated pulmonary hypertension, pulmonary edema, and thromboxane B2 release. Application of the techniques of gene transfer to the therapy of acute lung injury may prove feasible.
Methods
Plasmid construction. An ovine PGH synthase plasmid (pCMV4-PGH) was constructed in the pCMV4 expression vector (a generous gift from Dr. Mark Magnuson, Vanderbilt University) using linker-primer polymerase chain reaction and a proofreading, high temperature DNA polymerase (Vent DNA polymerase; New England Biolabs, Beverly, MA) (1 1, 12) . This construct uses the promoter region ofthe cytomegalovirus major immediate early gene to drive the expression of ovine PGH synthase. The pCMV4-PGH plasmid was propagated in Escherichia coli and purified using standard procedures (13).
Expression ofPGH synthase in vitro. BPAEC were grown to confluence in 100-mm petri plates in DME and 10% FCS plus penicillin and streptomycin. At the time of transfection, the medium was replaced with DME without FCS. 15 ,g ofplasmid DNA were combined with 45 ,g of Lipofectin" reagent (Gibco-Bethesda Research Laboratories, Gaithersburg, MD) and added to the medium for 12 h. At the end of the 12-h period, serum-free medium was removed and DME + 10% FCS was added.
PGH synthase protein analysis. BPAEC from transfection experiments were harvested 24, 48, and 72 h after transfection by scraping in phosphate-buffered saline and collected by centrifugation (500 g, 10 min). The cell pellet was lysed by sonication in the presence of 0.1% Triton X-100 (Sigma Immunochemicals, St. Louis, MO), and protein was determined by the Coomassie blue method of Read and Northcote (14). An aliquot (100 gg) of each protein sample was subjected to PAGE under denaturing conditions using standard methods (15) . After electrophoresis, the protein was electrically transferred to a sheet of nitrocellulose in a Transblot chamber (Bio-Rad Laboratories, Melville, NY).
Immunodetection ofPGH synthase was performed using published methods (16) . The initial antisera was a rabbit antisheep PGH synthase (PG 120; Oxford Biologicals, Oxford, MI), which cross-reacts with PGH synthase from a number of species including rabbit, and the second antiserum was goat antirabbit IgG with an alkaline phosphataseconjugated group (The Binding Site, San Diego, CA). The substrate cleaved by the alkaline phosphatase was 5-bromo4-indoyl phosphate, which yielded a chromogenic product in the presence ofnitroblue tetrazolium. Laser densitometry was performed (Ultrascan Laser Densitometer; LKB Instruments Inc., Bromma, Sweden), and the resulting data were analyzed using the gel scan software package (LKB-Pharmacia, Inc., Piscataway, NJ).
Eicosanoid analysis. Samples of perfusate were purified by solidphase extraction and then assayed for 6-keto-PGF1, (the stable metabolite of prostacyclin), PGE2, and thromboxane B2 using a competitive enzyme-linked immunoassay (17) . This assay also was used to measure eicosanoids in supernatants from organ cultures and from cell cultures. Urine was obtained from control and experimental rabbits by bladder aspiration at the time of surgery and analyzed for 2,3-dinor-6-keto-PGFI,,, by stable isotope dilution methods in conjunction with gas chromatography/mass spectrometry using previously reported methods (18) . In situ hybridization. Tissue in situ hybridization was performed as previously described (19) (20) (21) . Immediately upon death, the lungs were removed and placed in freshly prepared 4% paraformaldehyde in PBS (10 mM potassium phosphate, 150 mM NaCl, pH 7.4) at 4°C for 12-24 h. The vasculature was flushed with PBS and the lungs were fixed at a constant pressure of 35 cm of H20. The tissue were then dehydrated through graded (30, 50, 70 , and 90%) ethanol and xylene, and embedded in paraffin wax. 5-Mm thick sections were cut, floated on diethyl pyrocarbonate treated water, mounted on acid-washed, poly L-lysine coated glass slides and dried for 2 h at 55°C. Sections were brought to PBS and treated with I ,g/ml nuclease free proteinase K (Sigma Immunochemicals) for 15 min at 37°C followed by treatment with 0.1 M triethanolamine buffer, pH 8.0, for 5 min, and then freshly prepared triethanolamine buffer containing 0.25% acetic anhydride. Slides were then washed twice in 2x SSC (5 min in each) and dehydrated through graded alcohols and air dried.
Slides were hybridized with a single-stranded sense and antisense RNA probe as described below. The antisense probe was generated by digesting pCMV4-PGH plasmid with the restriction endonuclease Kpn 1 and performing a PCR reaction using a single primer complementary to bases 1683-1703 (PGH) and including [33P]dATP in the reaction mixture. A sense probe was made as described above using the restriction endonuclease XbaI and a primer identical to PGH synthase bases 1-20. The single-stranded PCR product was purified by chromatography through a Sephadex G-50 spin column. Hybridization was accomplished by applying 25 Ml ofhybridization buffer containing 50%
formamide, 2x SSC, 20 mM Tris, pH 8.0, 1x Denhardt's solution, 1 mM EDTA, 10% dextran sulfate, 100 mM dithiothreitol, 0.5 mg/ml yeast transfer RNA, and 2.5 X 104 cpm 33P-labeled RNA probe to the dry section and incubating overnight at 550C. Coverslips were placed over the sections during each hybridization step.
After incubation, the coverslips were removed and the slides were washed twice in 2x SSC containing 25 mM 0-mercaptoethanol at room temperature. These sections were then washed at room temperature for 5 min in 0.5X SSC followed by a further wash in 0.1x SSC containing 0-mercaptoethanol at 60'C. Next, the sections were washed in 0.5 M NaCl, 10 mM Tris HC1, 5 mM EDTA (TEN buffer) at 370C. The sections were then washed twice in 2x SSC for 15 min at room temperature and then in 0.1 x SSC for 15 min at 650C followed by a room temperature wash.
Sections were treated in 50% Ilford L5 emulsion (Polysciences, Inc., Warrington, PA), dried and left to expose at 4VC for were established in DME supplemented with 10% FCS and antibiotics (penicillin and streptomycin), and PGE2 and prostacyclin levels were measured in the medium after 24 h incubation at 37°C in a 95% 02 and 5% CO2 atmosphere. Control rabbits were treated identically, except that they were transfected with a pCMV4 plasmid that did not contain the PGH synthase coding sequence. RNA analysis. 24 h after transfection with either empty pCMV4 or pCMV4-PGH synthase by the protocol described above, animals were given an overdose of thiopental sodium. The lungs, liver, and kidneys were removed, 1 g of each tissue was homogenized in guanidinium isothiocyanate, and total RNA was isolated as previously described (22) . The quality of the RNA was determined by electrophoresis in a 1.2% agarose denaturing gel. After electrophoresis of 20 Mg of total RNA from all three organs on a 1.2% agarose denaturing gel, the RNA was transferred by capillary action to a nylon membrane (Amersham Corp., Arlington Heights, IL). Northern analysis was performed on the transferred RNA using ovine PGH synthase cDNA as a probe and standard methods (23) .
Reverse transcriptase PCR, a more sensitive method ofRNA detection, was performed using 6 Mg of lung RNA from both control and experimental animals (24). The lung RNA was combined with a 20-mer primer complementary to ovine PGH synthase mRNA between bases 1680 and 1700, Tet z buffer, 200 MM dNTP, and high temperature reverse transcriptase (5 U) (Tet z; Amersham Corp.) and incubated at 62°C for 15 min. After first strand cDNA synthesis was complete, two primers, 328 bases apart at the 5' end ofPGH synthase cDNA, were added with 200MM dNTP and plaque-forming units DNA polymerase (1 U) (Stratagene, La Jolla, CA), and a polymerase chain reaction was performed for 35 cycles. The resultant bands were visualized by staining with ethidium bromide after electrophoresis through a 2% agarose gel. Ovine PGH synthase yields a 328-bp band.
In situ-perfused lungpreparation. 24 h after transfection with either pCMV4-PGH or empty pCMV4 vector by the protocol described above, rabbits were weighed and restrained. 3-4 ml of an anesthetic solution, 1 part thiopental sodium (16 mg/ml) in 2 parts heparinized saline, were infused via a marginal ear vein. The animal was removed from the restraint and secured in the supine position. After a second
In Vivo Hyperextension ofthe Prostaglandin G/H Synthase Gene 1835 bolus of anesthetic was administered, a tracheostomy was performed, and the animal was ventilated at a tidal volume of 30 ml at a rate of40 breaths per minute. A carotid artery was cannulated, and 3,000-4,000 U of heparin were infused via the cannula. After 5 min, the rabbit was rapidly exsanguinated, and the shed blood was used as perfusate, maintained at 380C.
A midline incision was made below the xiphoid process, and a parasternal incision was made to allow extirpation of the costal cartilages. The inferior vena cava, descending aorta, and esophagus were ligated and a urine sample was obtained for eicosanoid analysis by direct bladder puncture. The pericardium was opened, and the main pulmonary artery was ligated with a loosely tied suture. The heart was incised immediately proximal to the pulmonic valve, and the inflow cannula was tied in the main pulmonary artery. The apex of the heart was removed, and the outflow cannula was inserted through the mitral valve into the left atrium. The perfusion system was checked for air bubbles, the pulmonary artery ligature was removed, and pulmonary perfusion at 100 ml/min (hematocrit 25-28%) and positive pressure ventilation (3 ml/kg, rate 20 with 5% CO2 in room air) were started. After 30 min, to establish stable baseline values, a single bolus ofLPS (4 jig/kg original body wt) was added to the perfusate. Pulmonary arterial pressure was constantly monitored via transducer (Validyne Engineering Corp., Northridge, CA) and an electronic recorder (Hewlett-Packard Co., Palo Alto, CA). Aliquots ofblood were withdrawn (and immediately combined with 50 ,g of indomethacin) at 10-min intervals for measurements. The lungs were maintained with blood perfusion at constant flow (100 ml/min) and positive pressure ventilation during the entire experiment. As an additional measure oflung injury, a piece of rabbit lung was removed at the end of the in situ perfusion experiments, and the ratio ofthe weight ofthe tissue before and after desiccation (wet/dry ratio) was determined (25) .
Statistics. Statistical evaluation of the data was performed using True Epistat, Ver. 4 (Epistat Services, Richardson, TX).
Results
Transfection ofBPAEC in culture with the PGH synthase gene.
BPAEC transfected with pCMV4-PGH synthase/liposome complex produced twofold increased amounts of6-keto-PGFa (10.5 ng/24 h per 100-mm plate) compared to 5.8 for cells transfected with a PGH synthase-free plasmid. Fig. shows (Fig. 2, A and B) shows that -20% of the BPAEC transcribes the PGH synthase transgene.
In vivo transfection ofPGH synthase cDNA. Production of both PGE2 and prostacyclin was six-to eightfold higher in organ cultures of lung from rabbits transfected with PGH synthase than in empty vector-transfected controls (Fig. 3) . In separate experiments, organ cultures were established in the presence of radiolabeled PGE2, and no differences in PGE2 half-life were observed (data not shown) between animals transfected with PGH synthase and empty vector-transfected controls. Plasma concentrations of 6-keto-PGF1a were higher at baseline in rabbits transfected with the ovine gene (6- PGH synthase mRNA was not detected by Northern blot analysis. This may reflect either the extremely transient nature ofthe PGH synthase message or indicate that a low percentage of cells was successfully transfected in vivo. mRNA for ovine PGH synthase was present in the lungs oftransfected rabbits as shown by RT-PCR but was not detected in kidney or liver (Fig.  4) . Successful in vivo transfection of ovine PGH synthase was demonstrated in rabbit lung by in situ hybridization. Sections of rabbit lung were probed with either an antisense probe ( In situ lung studies. LPS caused a rapid and progressive increase in mean pulmonary artery pressure in nontransfected lungs (data not shown) and in the lungs of the rabbits transfected with empty pCMV4 vector (Fig. 6) . Experiments in the empty vector-transfected controls were terminated within 90 min ofendotoxin infusion because ofsevere pulmonary hypertension. Lungs of rabbits transfected with the PGH synthase gene showed only minimal increases in pulmonary arterial pressure after the administration of LPS.
The average pulmonary artery pressure in the control group at the 50-min time point was 91.2±52.2 cm of water (four animals). The average pulmonary arterial pressure in the transfected rabbits at the 50-min time point was significantly lower at 18.3±2.2 cm ofwater (four animals) (P < 0.05). The average wet/dry weight ratio ofthe LPS-treated control animals (n = 3) was 8.4±1.8, while the ratio in the PGH synthase transfected group (n = 4) was 4.79±0.3 (P < 0.05).
Perfusate thromboxane concentrations were 10-fold higher in the empty vector-transfected control group than in the per- fusate of rabbits transfected with pCMV4-PGH at 50 and 60 min after endotoxin (n = 3, P < 0.05) (Fig. 7) . 6-keto-PGF,1 and PGE2 concentration in the perfusate during in situ lung studies were highly variable and showed no consistent pattern in either empty vector-transfected controls or rabbits transfected with pCMV4-PGH, possibly as a consequence of the trauma of the preparation (26) .
Discussion
We previously demonstrated successful transfection ofBPAEC and of the lungs of intact animals with genes encoding chloramphenicol acetyltransferase, human growth hormone, and a-1 antitrypsin ( 1-3). Because cyclooxygenase products ofarachidonic acid are important in lung homeostasis and in inflammatory responses, we tested the feasibility and effects of transfection with PGH synthase, a key enzyme in prostaglandin synthesis.
The ovine PGH synthase gene was successfully transfected in BPAEC. This was demonstrated by increased release of the primary arachidonic acid metabolites from vascular endothe- lium, PGE2 and prostacyclin, increased levels of intracellular PGH synthase protein, and demonstration of transgene message by in situ hybridization. Lungs removed from animals 24 h after intravenous transfection with the PGH synthase gene produced increased amounts of PGE2 and prostacyclin in organ cultures. Urine from PGH synthase-transfected animals contained increased amounts of prostacyclin metabolite. mRNA specific for the ovine PGH synthase transgene was found in the lungs of the transfected rabbits by reverse transcriptase-PCR, and transgene message was detected in the lung periphery by in situ hybridization.
These data demonstrate that cationic liposomes can deliver a functioning plasmid vector expressing the PGH synthase gene to lung endothelial cells in culture and to the lungs of intact animals. Expression ofthe PGH synthase gene sufficient to increase production of the endothelium-derived eicosanoids, prostacyclin and PGE2, can be achieved by this methodology both in cultured cells and in vivo.
In situ perfused lung studies were performed 24 h after transfection. This time point was selected because BPAEC harvested 24 h after transfection produced the greatest amount of immunoreactive PGH synthase. Transgene expression continues for a longer period, as we have shown increased prostacyclin in the medium from organ cultures that were established 48 h after the animal was transfected with the cDNA for ovine PGH synthase. In vivo transfection with a pCMV4 construct containing the cDNA coding for human a-l-antitrypsin results in expression of a-1-antitrypsin for 2 7 d (27) .
Lipopolysaccharide (endotoxin) from Gram-negative bacteria causes many pathophysiologic alterations in the lung, including pulmonary hypertension and edema (28) . Studies with cyclooxygenase inhibitors and thromboxane-endoperoxide antagonists suggest that much of the LPS induced increase in pulmonary arterial pressure is a consequence of increased production ofthromboxane A2 (29) . In previous studies in chronically instrumented sheep, infusion ofPGE2 attenuated LPS-induced pulmonary hypertension and decreased thromboxane generation (10) . In the rabbit perfused lung model, the thromboxane receptor blocker SQ-29548 attenuates LPS-induced pulmonary hypertension (Parker, R. E., personal communication). Prostacyclin is a pulmonary vasodilator and through its antiplatelet effect, can inhibit thromboxane generation (30) . Thus increased levels of PGE2 and prostacyclin might lower thromboxane A2 to levels that could in turn result in an attenuation of pulmonary hypertension observed after LPS challenge.
We hypothesized that intravenous delivery of pCMV4-PGH might preferentially transfect pulmonary endothelium, resulting in increased generation ofprostacyclin and PGE2 and attenuation of the LPS response. We recently demonstrated that plasmid DNA labeled with [33P]dCTP combined with cationic liposomes and injected intravenously into rabbits localizes in the vascular endothelium of the lung (27) . The in situ hybridization data reported here are consistent with localization of transgene expression in peripheral lung endothelium. Increased prostacyclin and PGE2 production in PGH synthase transfected animals is also consistent with endothelial expression of the transgene.
In an in situ lung preparation, we demonstrated marked attenuation ofpulmonary hypertension and pulmonary edema in response to endotoxin in the lungs of animals transfected with the PGH synthase gene. We also showed that the perfusate from the rabbits transfected with pCMV4-PGH contained much less thromboxane after LPS challenge than in animals transfected identically with the empty vector.
We show that a recombinant gene can be expressed and have functional consequences in the lungs in vivo using a plasmid vector and liposome-mediated gene delivery. This method has the advantages ofdirect gene delivery to lung cells. The use of plasmids as the DNA source should minimize the risk of integration ofthe transfected gene into the host genome. These studies demonstrate that when a gene coding for a catalytically active enzyme is transfected, sufficient amounts ofthe reactive product(s) can be produced by the enzyme to significantly alter a physiological response even under circumstances where the amount of mRNA coding for the transfected gene may be low.
This approach to gene hyperexpression minimizes many of the potential complications of gene therapy and has potential to be useful in the treatment of both acquired and inherited diseases. Use ofthese methods in therapy ofacute lung injury is especially attractive because there is no current therapy with proven efficacy, a single administration ofplasmid would probably be sufficient and only transient expression of the foreign gene is needed.
